Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

CEO appointment and Board changes

12 May 2022 07:15

RNS Number : 1833L
Plant Health Care PLC
12 May 2022
 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

CEO appointment and Board changes

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce the appointment of a new Chief Executive Officer and consequent changes to the Board.

 

Highlights

 

· Jeff Tweedy, currently the Company's Chief Operating Officer, will be appointed Chief Executive Officer (CEO) with effect from the Annual General Meeting on June 22nd, 2022

· At the same time, Chris Richards, currently CEO, will be appointed Non-Executive Chairman of the Board and Richard Webb, currently Non-Executive Chairman, will step down from the Board. 

 

Chris Richards stepped in as CEO in November 2017, having previously been Chairman since August 2012. By appointing Chris to the role of Non-Executive Chairman, the Company continues to benefit from his deep experience. At the same time, Richard Webb, currently Non-Executive Chairman, will step down from the Board to pursue other interests.

 

Chris Richards, CEO of Plant Health Care said, ‟I am delighted with the appointment of Jeff Tweedy as my successor, in line with our long-established succession plan. Jeff has delivered consistent and exceptional performance as COO and has earned the respect of both internal and external stakeholders. He is the perfect person to lead the company into its exciting next phase of growth. It will be an honour to support Jeff in his new role, where I have no doubt that his energy, commitment and professionalism will deliver continued success for Plant Health Care over the coming years. 

 

"On behalf of the entire Board, I would like to express our most heartfelt thanks to Richard Webb. Richard was instrumental in the early strategic development of the company, especially in working with Dr Zhongmin Wei on the research which has delivered the enormously exciting PREtec product pipeline. As such, Richard has made an incomparable contribution to the Company. We wish him every success in his new endeavours."

 

Background

Jeff Tweedy joined Plant Health Care in October 2017 as Commercial Head for North America, then promoted to Global Head of Commercial in 2020. He was then appointed Chief Operating Officer of Plant Health Care and a member of the Board of Directors in November 2019. Jeff has progressively taken on more responsibilities and discharged them with great success. Over the last 18 months, he has led most of the day-to-day operations of the Company. Under Jeff's leadership, the Company has delivered robust financial performance and successfully brought forward the exceptionally promising PREtec ('Vaccines for Plants') product pipeline. In light of this performance, the Board unanimously agreed to appoint Jeff as Chief Executive Officer of Plant Health Care (CEO), with effect from the end of the Annual General Meeting on June 22nd, 2022.

 

With effect from June 22nd, Jeff Tweedy will be responsible for running the Company. Chris Richards will be available to mentor Jeff and to provide support for corporate development and investor relations.

 

Richard Webb has been a valued member of the Board since 2013 and has made an invaluable contribution to the Company's strategy, especially in supporting the discovery and development of PREtec.

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile. Find out more at Vox Markets and the company website: www.planthealthcare.com

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

For further information, please contact:

 

Plant Health Care plc

 

Jeff Hovey, CFO

+1 919 926 1600

Cenkos Securities plc - Nomad and Broker

 

Neil McDonald / Peter Lynch

+44 (0) 20 7391 8900

Vox Markets - Digital Investor Relations

 

Paul Cornelius / Kat Perez

+44 (0) 7866 384707

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAABMRTMTJBBBT
Date   Source Headline
1st Jun 200911:37 amRNSTotal Voting Rights
1st Jun 20097:00 amRNSEuropean Patent Granted for Harpin
28th May 20095:51 pmRNSAdditional Listing
28th May 20095:23 pmRNSSignificant Shareholding
28th May 20098:47 amRNSHolding(s) in Company
20th May 20099:30 amRNSAdditional Listing
19th May 20098:00 amRNSTest results
18th May 20093:47 pmRNSDirector/PDMR Shareholding
18th May 200910:44 amRNSAdditional Listing
13th May 20091:15 pmRNSDirector/PDMR Shareholding
12th May 200911:53 amRNSEGM Statement
30th Apr 200912:41 pmRNSDirector/PDMR Shareholding
24th Apr 200911:50 amRNSPlacing Announcement
16th Apr 20095:01 pmRNSAnnual Financial Report
15th Apr 20095:20 pmRNSAdditional Listing
2nd Apr 20095:47 pmRNSMonsanto Order
1st Apr 20093:40 pmRNSAdditional Listing
30th Mar 20097:00 amRNSDirector/PDMR Shareholding
24th Mar 200910:49 amRNSChange of Registered Office
24th Mar 20097:00 amRNSFinal Results
2nd Mar 200910:06 amRNSTotal Voting Rights
2nd Feb 200912:53 pmRNSTotal Voting Rights
2nd Feb 200911:01 amRNSBoard Appointment
28th Jan 20094:36 pmRNSPrice Monitoring Extension
28th Jan 20097:00 amRNSAdditional Listing
22nd Jan 20097:00 amRNSTrading Statement
15th Jan 20097:00 amRNSNew Appointments
5th Jan 20099:57 amRNSSignificant Shareholding
31st Dec 200811:19 amRNSTotal Voting Rights
19th Dec 20084:22 pmRNSHolding(s) in Company
18th Dec 20087:01 amRNSFurther re Myconate
18th Dec 20087:00 amRNSTermination of Agreement
16th Dec 20087:00 amRNSFinal Agreement with Monsanto
1st Dec 200810:02 amRNSTotal Voting Rights
26th Nov 20087:00 amRNSField Trials
18th Nov 200812:21 pmRNSAdditional Listing
31st Oct 20083:35 pmRNSTotal Voting Rights
30th Oct 20084:01 pmRNSBoard Appointment
20th Oct 200811:26 amRNSHolding(s) in Company
8th Oct 20081:05 pmRNSSignificant shareholding
2nd Oct 20087:52 amRNSField Trials
30th Sep 20088:00 amRNSTotal Voting Rights
25th Sep 20087:00 amRNSRe Scotts agreement
23rd Sep 20087:00 amRNSPreTect Field Trial Results
17th Sep 20087:00 amRNSAgreement with Bayer CropScience
15th Sep 20082:06 pmRNSPosting of Interim Results
9th Sep 20084:32 pmRNSDirector/PDMR Shareholding
8th Sep 20087:01 amRNSSupply Agreement
8th Sep 20087:00 amRNSInterim Results
1st Sep 200810:03 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.